These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38716991)
21. New device indications: practice and cost implications in Europe. Morgan JM; ; Card Electrophysiol Rev; 2003 Jan; 7(1):49-53. PubMed ID: 12766518 [TBL] [Abstract][Full Text] [Related]
22. [Efficiency potential in the pacemaker/implantable cardioverter defibrillator outpatient clinic]. Bauer A; Bauer J; Bauer M; Kelemen K; Voss F; Senges-Becker J; Weretka S; Katus HA; Becker R Herzschrittmacherther Elektrophysiol; 2006 Mar; 17(1):26-34. PubMed ID: 16547657 [TBL] [Abstract][Full Text] [Related]
23. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation. Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917 [TBL] [Abstract][Full Text] [Related]
25. Costs and complications associated with transvenous lead reoperation in cardiac implantable electronic devices. Griffiths RI; Amorosi SL; Jacobsen CM; McBee PJ; Menzin J; Reynolds MR J Cardiovasc Electrophysiol; 2020 Feb; 31(2):503-511. PubMed ID: 31916328 [TBL] [Abstract][Full Text] [Related]
26. What costs matter? Rethinking social costs of new device technologies. Choby AA; Clark AM Europace; 2013 Nov; 15(11):1538-9. PubMed ID: 23833047 [No Abstract] [Full Text] [Related]
27. [Extraction of chronically implanted transvenous pacing and defibrillator leads - cost analysis]. Kempa M; Budrejko S; Beta S; Piepiorka M; Rogowski J; Raczak G Kardiol Pol; 2012; 70(1):96-9. PubMed ID: 22267441 [TBL] [Abstract][Full Text] [Related]
28. Long-term effectiveness of cardiac resynchronization therapy: Futile or useful? Exner DV Can J Cardiol; 2005 Apr; 21(5):419-22. PubMed ID: 15861259 [No Abstract] [Full Text] [Related]
29. Remote monitoring costs, benefits, and reimbursement: a European perspective. Chronaki CE; Vardas P Europace; 2013 Jun; 15 Suppl 1():i59-i64. PubMed ID: 23737233 [TBL] [Abstract][Full Text] [Related]
30. Centers for Medicare and Medicaid Services will stop payment for infected cardiac implantable devices; will implantable pain therapy be next? Welch M; Attalah J Pain Pract; 2013 Feb; 13(2):171. PubMed ID: 23379958 [No Abstract] [Full Text] [Related]